Sentinel lymph node biopsy in gynaecological cancers: The importance of micrometastases in cervical cancer

Surgical Oncology

Volumn 17, Issue 3, 2008, Pages 227-235

  Daraï, Emile ^a   Rouzier, Roman ^a   Ballester, Marcos ^a   Barranger, Emmanuel ^a   Coutant, Charles ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Cervical cancer; Immunohistochemistry; Lymph node metastasis; Micrometastases; Molecular biology; Prognosis; Sentinel lymph node; Serial sectioning

Indexed keywords

CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CASE CONTROL STUDY; GYNECOLOGIC CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; INCIDENCE; LONGITUDINAL STUDY; MICROMETASTASIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RISK FACTOR; SENTINEL LYMPH NODE BIOPSY; UTERINE CERVIX CANCER;

FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; REPRODUCIBILITY OF RESULTS; SENTINEL LYMPH NODE BIOPSY; UTERINE CERVICAL NEOPLASMS;

EID: 50249098635     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suronc.2008.04.002     Document Type: Review

References (70)

1. Greenlee R.T., Hill-Harmon M.B., Murray T., and Thun M. Cancer statistics. CA Cancer J Clin 2001 51 (2001) 15-36
2. Bosch F.X., and de Sanjose S. Chapter 1: Human papillomavirus and cervical cancer - burden and assessment of causality. J Natl Cancer Inst Monogr (2003) 3-13
3. Fuchs P.G., Girardi F., and Pfister H. Human papillomavirus 16 DNA in cervical cancers and in lymph nodes of cervical cancer patients: a diagnostic marker for early metastases?. Int J Cancer 43 (1989) 41-44
4. Juretzka M.M., Jensen K.C., Longacre T.A., Teng N.M., and Husain A. Detection of pelvic lymph node micrometastasis in stage IA2-IB2 cervical cancer by immunohistochemical analysis. Gynecol Oncol 93 (2004) 107-111
5. Martinez-Palones J.M., Gil-Moreno A., Perez-Benavente M.A., Roca I., and Xercavins J. Intraoperative sentinel node identification in early stage cervical cancer using a combination of radiolabeled albumin injection and isosulfan blue dye injection. Gynecol Oncol 92 (2004) 845-850
6. Wang H.Y., Sun J.M., Lu H.F., Shi D.R., Ou Z.L., Ren Y.L., et al. Micrometastases detected by cytokeratin 19 expression in sentinel lymph nodes of patients with early-stage cervical cancer. Int J Gynecol Cancer 16 (2006) 643-648
7. Morton D.L., Thompson J.F., Essner R., Elashoff R., Stern S.L., Nieweg O.E., et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 230 (1999) 453-463 [discussion 463-55]
8. Giuliano A.E., Kirgan D.M., Guenther J.M., and Morton D.L. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220 (1994) 391-398 [discussion 398-401]
9. Schwartz G.F., Giuliano A.E., and Veronesi U. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast April 19 to 22, 2001. Philadelphia, Pennsylvania. Hum Pathol 33 (2002) 579-589
10. de Hullu J.A., Doting E., Piers D.A., Hollema H., Aalders J.G., Koops H.S., et al. Sentinel lymph node identification with technetium-99m-labeled nanocolloid in squamous cell cancer of the vulva. J Nucl Med 39 (1998) 1381-1385
11. Plante M., Renaud M.C., Tetu B., Harel F., and Roy M. Laparoscopic sentinel node mapping in early-stage cervical cancer. Gynecol Oncol 91 (2003) 494-503
12. Stehman F.B., Bundy B.N., DiSaia P.J., Keys H.M., Larson J.E., and Fowler W.C. Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer 67 (1991) 2776-2785
13. Holmgren L., O'Reilly M.S., and Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1 (1995) 149-153
14. Echt M.L., Finan M.A., Hoffman M.S., Kline R.C., Roberts W.S., and Fiorica J.V. Detection of sentinel lymph nodes with lymphazurin in cervical, uterine, and vulvar malignancies. South Med J 92 (1999) 204-208
15. Marnitz S., Kohler C., Bongardt S., Braig U., Hertel H., Schneider A., et al. Topographic distribution of sentinel lymph nodes in patients with cervical cancer. Gynecol Oncol 103 (2006) 35-44
16. Barranger E., Cortez A., Commo F., Marpeau O., Uzan S., Darai E., et al. Histopathological validation of the sentinel node concept in cervical cancer. Ann Oncol 15 (2004) 870-874
17. Barranger E., Cortez A., Uzan S., Marpeau O., Uzan S., and Darai E. Value of intraoperative imprint cytology of sentinel nodes in patients with cervical cancer. Gynecol Oncol 94 (2004) 175-180
18. Buist M.R., Pijpers R.J., van Lingen A., van Diest P.J., Dijkstra J., Kenemans P., et al. Laparoscopic detection of sentinel lymph nodes followed by lymph node dissection in patients with early stage cervical cancer. Gynecol Oncol 90 (2003) 290-296
19. Chung Y.A., Kim S.H., Sohn H.S., Chung S.K., Rhim C.C., and Namkoong S.E. Usefulness of lymphoscintigraphy and intraoperative gamma probe detection in the identification of sentinel nodes in cervical cancer. Eur J Nucl Med Mol Imaging 30 (2003) 1014-1017
20. Dargent D., and Enria R. Laparoscopic assessment of the sentinel lymph nodes in early cervical cancer. Technique - preliminary results and future developments. Crit Rev Oncol Hematol 48 (2003) 305-310
21. Gil-Moreno A., Diaz-Feijoo B., Roca I., Puig O., Pérez-Benavente M.A., Aguilar I., et al. Total laparoscopic radical hysterectomy with intraoperative sentinel node identification in patients with early invasive cervical cancer. Gynecol Oncol 96 (2005) 187-193
22. Lantzsch T., Wolters M., Grimm J., Mende T., Buchmann J., Sliutz G., et al. Sentinel node procedure in Ib cervical cancer: a preliminary series. Br J Cancer 85 (2001) 791-794
23. Levenback C., Coleman R.L., Burke T.W., Lin W.M., Erdman W., Deavers M., et al. Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy. J Clin Oncol 20 (2002) 688-693
24. Marchiole P., Buenerd A., Scoazec J.Y., Dargent D., and Mathevet P. Sentinel lymph node biopsy is not accurate in predicting lymph node status for patients with cervical carcinoma. Cancer 100 (2004) 2154-2159
25. Torne A., and Puig-Tintore L.M. The use of sentinel lymph nodes in gynaecological malignancies. Curr Opin Obstet Gynecol 16 (2004) 57-64
26. Reiffenstuhl G. [Contribution on the nomenclature of the pelvic lymph nodes]. Wien Klin Wochenschr 68 (1956) 247-248
27. Plentl A.A., and Friedman E.A. Lymphatic system of the female genitalia. The morphologic basis of oncologic diagnosis and therapy. Major Probl Obstet Gynecol 2 (1971) 1-223
28. Benedetti-Panici P., Maneschi F., Scambia G., Greggi S., Cutillo G., D'Andrea G., et al. Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. Gynecol Oncol 62 (1996) 19-24
29. Hockel M. Do we need a new classification for radical hysterectomy? Insights in surgical anatomy and local tumor spread from human embryology. Gynecol Oncol 107 (2007) S106-S112
30. Hockel M., and Dornhofer N. Pelvic exenteration for gynaecological tumours: achievements and unanswered questions. Lancet Oncol 7 (2006) 837-847
31. Dargent D., Martin X., and Mathevet P. Laparoscopic assessment of the sentinel lymph node in early stage cervical cancer. Gynecol Oncol 79 (2000) 411-415
32. Medl M., Peters-Engl C., Schutz P., Vesely M., and Sevelda P. First report of lymphatic mapping with isosulfan blue dye and sentinel node biopsy in cervical cancer. Anticancer Res 20 (2000) 1133-1134
33. O'Boyle J.D., Coleman R.L., Bernstein S.G., Lifshitz S., Muller C.Y., and Miller D.S. Intraoperative lymphatic mapping in cervix cancer patients undergoing radical hysterectomy: a pilot study. Gynecol Oncol 79 (2000) 238-243
34. Rob L., Strnad P., Robova H., Charvat M., Pluta M., Schlegerova D., et al. Study of lymphatic mapping and sentinel node identification in early stage cervical cancer. Gynecol Oncol 98 (2005) 281-288
35. Angioli R., Palaia I., Cipriani C., Muzii L., Calcagno M., Gullotta G., et al. Role of sentinel lymph node biopsy procedure in cervical cancer: a critical point of view. Gynecol Oncol 96 (2005) 504-509
36. Lin Y.S., Tzeng C.C., Huang K.F., Kang C.Y., Chia C.C., and Hsieh J.F. Sentinel node detection with radiocolloid lymphatic mapping in early invasive cervical cancer. Int J Gynecol Cancer 15 (2005) 273-277
37. Silva L.B., Silva-Filho A.L., Traiman P., Triginelli S.A., de Lima C.F., Siqueira C.F., et al. Sentinel node detection in cervical cancer with (99m)Tc-phytate. Gynecol Oncol 97 (2005) 588-595
38. van Dam P.A., Hauspy J., Vanderheyden T., Sonnemans H., Spaepen A., Eggenstein G., et al. Intraoperative sentinel node identification with Technetium-99m-labeled nanocolloid in patients with cancer of the uterine cervix: a feasibility study. Int J Gynecol Cancer 13 (2003) 182-186
39. Barranger E., Grahek D., Cortez A., Talbot J.N., Uzan S., and Darai E. Laparoscopic sentinel lymph node procedure using a combination of patent blue and radioisotope in women with cervical carcinoma. Cancer 97 (2003) 3003-3009
40. Lambaudie E., Collinet P., Narducci F., Sonoda Y., Papageorgiou T., Carpentier P., et al. Laparoscopic identification of sentinel lymph nodes in early stage cervical cancer: prospective study using a combination of patent blue dye injection and technetium radiocolloid injection. Gynecol Oncol 89 (2003) 84-87
41. Malur S., Krause N., Kohler C., and Schneider A. Sentinel lymph node detection in patients with cervical cancer. Gynecol Oncol 80 (2001) 254-257
42. 99mTc phytate and patent blue. Gynecol Oncol 94 (2004) 528-532
43. Pijpers R., Buist M.R., van Lingen A., Dijkstra J., van Diest P.J., Teule G.J., et al. The sentinel node in cervical cancer: scintigraphy and laparoscopic gamma probe-guided biopsy. Eur J Nucl Med Mol Imaging 31 (2004) 1479-1486
44. Verheijen R.H., Pijpers R., van Diest P.J., Burger C.W., Buist M.R., and Kenemans P. Sentinel node detection in cervical cancer. Obstet Gynecol 96 (2000) 135-138
45. Wydra D., Lass P., and Bandurski T. Usefulness of lymphoscintigraphy and intraoperative gamma probe detection in the identification of sentinel nodes in cervical cancer. Eur J Nucl Med Mol Imaging 31 (2004) 293 author reply 294
46. Frumovitz M., Coleman R.L., Gayed I.W., Ramirez P.T., Wolf J.K., Gershenson D.M., et al. Usefulness of preoperative lymphoscintigraphy in patients who undergo radical hysterectomy and pelvic lymphadenectomy for cervical cancer. Am J Obstet Gynecol 194 (2006) 1186-1193 [discussion 1193-5]
47. Barranger E., Coutant C., Cortez A., Uzan S., and Darai E. Sentinel node biopsy is reliable in early-stage cervical cancer but not in locally advanced disease. Ann Oncol 16 (2005) 1237-1242
48. Di Stefano A.B., Acquaviva G., Garozzo G., Barbic M., Cvjeticanin B., Meglic L., et al. Lymph node mapping and sentinel node detection in patients with cervical carcinoma: a 2-year experience. Gynecol Oncol 99 (2005) 671-679
49. Hubalewska A., Sowa-Staszczak A., Huszno B., Markocka A., Pityński K., Basta A., et al. Use of Tc99m-nanocolloid for sentinel nodes identification in cervical cancer. Nucl Med Rev Cent East Eur 6 (2003) 127-130
50. Marchiole P., Buenerd A., Benchaib M., Nezhat K., Dargent D., and Mathevet P. Clinical significance of lympho vascular space involvement and lymph node micrometastases in early-stage cervical cancer: a retrospective case-control surgico-pathological study. Gynecol Oncol 97 (2005) 727-732
51. Hafner N., Gajda M., Altgassen C., Hertel H., Greinke C., Hillemanns P., et al. HPV16-E6 mRNA is superior to cytokeratin 19 mRNA as a molecular marker for the detection of disseminated tumor cells in sentinel lymph nodes of patients with cervical cancer by quantitative reverse-transcription PCR. Int J Cancer 120 (2007) 1842-1846
52. Cote R.J., Peterson H.F., Chaiwun B., Gelber R.D., Goldhirsch A., Castiglione-Gertsch M., et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet 354 (1999) 896-900
53. Raj G.V., Moreno J.G., and Gomella L.G. Utilization of polymerase chain reaction technology in the detection of solid tumors. Cancer 82 (1998) 1419-1442
54. Smith B., Selby P., Southgate J., Pittman K., Bradley C., and Blair G.E. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 338 (1991) 1227-1229
55. Van Trappen P.O., Gyselman V.G., Lowe D.G., Ryan A., Oram D.H., Bosze P., et al. Molecular quantification and mapping of lymph-node micrometastases in cervical cancer. Lancet 357 (2001) 15-20
56. Coutant C., Barranger E., Cortez A., Dabit D., Uzan S., Bernaudin J.F., et al. Frequency and prognostic significance of HPV DNA in sentinel lymph nodes of patients with cervical cancer. Ann Oncol 18 (2007) 1513-1517
57. van der Velde-Zimmermann D., Schipper M.E., de Weger R.A., Hennipman A., and Borel Rinkes I.H. Sentinel node biopsies in melanoma patients: a protocol for accurate, efficient, and cost-effective analysis by preselection for immunohistochemistry on the basis of Tyr-PCR. Ann Surg Oncol 7 (2000) 51-54
58. Sartori E., Tisi G., Chiudinelli F., La Face B., Franzini R., and Pecorelli S. Early stage cervical cancer: adjuvant treatment in negative lymph node cases. Gynecol Oncol 107 (2007) S170-S174
59. Lentz S.E., Muderspach L.I., Felix J.C., Ye W., Groshen S., and Amezcua C.A. Identification of micrometastases in histologically negative lymph nodes of early-stage cervical cancer patients. Obstet Gynecol 103 (2004) 1204-1210
60. Knopp S., Holm R., Trope C., and Nesland J.M. Occult lymph node metastases in early stage vulvar carcinoma patients. Gynecol Oncol 99 (2005) 383-387
61. Narayansingh G.V., Miller I.D., Sharma M., Welch C.J., Sharp L., Parkin D.E., et al. The prognostic significance of micrometastases in node-negative squamous cell carcinoma of the vulva. Br J Cancer 92 (2005) 222-224
62. Hakim A.A., and Terada K.Y. Sentinel node dissection in vulvar cancer. Curr Treat Options Oncol 7 (2006) 85-91
63. Yuan S.H., Xiong Y., Wei M., Yan X.J., Zhang H.Z., Zeng Y.X., et al. Sentinel lymph node detection using methylene blue in patients with early stage cervical cancer. Gynecol Oncol 106 (2007) 147-152
64. Seong S.J., Park H., Yang K.M., Kim T.J., Lim K.T., Shim J.U., et al. Detection of sentinel lymph nodes in patients with early stage cervical cancer. J Korean Med Sci 22 (2007) 105-109
65. Li B., Zhang W.H., Liu L., Wu L.Y., Zhang R., and Li N. Sentinel lymph node identification in patients with early stage cervical cancer undergoing radical hysterectomy and pelvic lymphadenectomy. Chin Med J (Engl) 117 (2004) 867-870
66. Kamprath S., Possover M., and Schneider A. Laparoscopic sentinel lymph node detection in patients with cervical cancer. Am J Obstet Gynecol 182 (2000) 1648
67. Kraft O., Sevcik L., Klat J., Koliba P., Curík R., and Kríozvá H. Detection of sentinel lymph nodes in cervical cancer. A comparison of two protocols. Nucl Med Rev Cent East Eur 9 (2006) 65-68
68. Lee Y.S., Rhim C.C., Lee H.N., Lee K.H., Park J.S., and Namkoong S.E. HPV status in sentinel nodes might be a prognostic factor in cervical cancer. Gynecol Oncol 105 (2007) 351-357
69. Hauspy J., Beiner M., Harley I., Ehrlich L., Rasty G., and Covens A. Sentinel lymph nodes in early stage cervical cancer. Gynecol Oncol 105 (2007) 285-290
70. Bats A.S., Clement D., Larousserie F., Lefrère-Belda M.A., Faraggi M., Froissart M., et al. Sentinel lymph node biopsy improves staging in early cervical cancer. Gynecol Oncol 105 (2007) 189-193